Crescent Capital BDC (NASDAQ:CCAP) Given New $17.00 Price Target at Raymond James

Crescent Capital BDC (NASDAQ:CCAPFree Report) had its price objective cut by Raymond James from $20.00 to $17.00 in a report published on Friday,Benzinga reports. They currently have an outperform rating on the stock.

A number of other equities research analysts have also commented on CCAP. Keefe, Bruyette & Woods lowered Crescent Capital BDC from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $18.50 to $17.00 in a research report on Friday. Wells Fargo & Company reduced their price target on shares of Crescent Capital BDC from $16.00 to $15.00 and set an “equal weight” rating for the company in a research report on Friday. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $17.60.

Check Out Our Latest Stock Analysis on CCAP

Crescent Capital BDC Trading Down 3.3%

NASDAQ CCAP opened at $15.42 on Friday. Crescent Capital BDC has a twelve month low of $13.54 and a twelve month high of $20.19. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.32. The stock has a market cap of $571.47 million, a price-to-earnings ratio of 7.75 and a beta of 0.63. The firm’s 50 day moving average price is $16.19 and its two-hundred day moving average price is $18.07.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last issued its earnings results on Wednesday, May 14th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.52 by ($0.07). Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. The business had revenue of $42.13 million during the quarter, compared to analyst estimates of $45.08 million. Equities analysts anticipate that Crescent Capital BDC will post 2.09 EPS for the current year.

Crescent Capital BDC Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Monday, June 30th will be given a dividend of $0.42 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $1.68 dividend on an annualized basis and a yield of 10.89%. Crescent Capital BDC’s payout ratio is 84.42%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Montag A & Associates Inc. purchased a new stake in shares of Crescent Capital BDC during the 4th quarter worth about $35,000. C M Bidwell & Associates Ltd. bought a new stake in shares of Crescent Capital BDC in the 4th quarter valued at approximately $39,000. Aquatic Capital Management LLC acquired a new position in Crescent Capital BDC in the fourth quarter worth approximately $129,000. Generation Capital Management LLC acquired a new position in Crescent Capital BDC in the fourth quarter worth approximately $192,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in Crescent Capital BDC during the fourth quarter valued at approximately $218,000. Hedge funds and other institutional investors own 49.46% of the company’s stock.

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Stories

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.